| Literature DB >> 32918449 |
John M Aalen1,2,3, Erwan Donal4, Camilla K Larsen1,2,3, Jürgen Duchenne5,6, Mathieu Lederlin3, Marta Cvijic5,6, Arnaud Hubert3, Gabor Voros5,6, Christophe Leclercq3, Jan Bogaert7,8, Einar Hopp9, Jan Gunnar Fjeld9,10, Martin Penicka11, Cecilia Linde12, Odd O Aalen13, Erik Kongsgård1,2,3, Elena Galli3, Jens-Uwe Voigt5,6, Otto A Smiseth1,2,3.
Abstract
AIMS: Left ventricular (LV) failure in left bundle branch block is caused by loss of septal function and compensatory hyperfunction of the LV lateral wall (LW) which stimulates adverse remodelling. This study investigates if septal and LW function measured as myocardial work, alone and combined with assessment of septal viability, identifies responders to cardiac resynchronization therapy (CRT). METHODS ANDEntities:
Keywords: Myocardial scar; Cardiac resynchronization therapy; Dyssynchrony; Heart failure; Left bundle branch block; Myocardial work
Mesh:
Year: 2020 PMID: 32918449 PMCID: PMC7599033 DOI: 10.1093/eurheartj/ehaa603
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983
Figure 1Left ventricular systolic function and work asymmetry. (A) Effect of cardiac resynchronization therapy on left ventricular volumes and function: Volumes and ejection fraction were similar in responders and non-responders before cardiac resynchronization therapy, but improved significantly only in responders. (B) Effects of cardiac resynchronization therapy on work: Before cardiac resynchronization therapy, responders have more work in the left ventricular lateral wall and less in the septum than non-responders (upper panels). This is reflected in a larger lateral-to-septal work difference (mid-panels). With cardiac resynchronization therapy, lateral wall work is reduced and septal work increased in both groups. Among responders, however, reduction in lateral wall work was far exceeded by increased septal work and explains why only responders showed improved global work (lower panels). One standard deviation indicated.
Figure 2Septal scar identifies non-responder to cardiac resynchronization therapy. (A) Strain traces (left), pressure-strain loops (middle), and regional work (right) in a representative non-responder (with non-ischaemic cardiomyopathy) prior to cardiac resynchronization therapy. Similar to the patient in the , there are highly inefficient septal contractions with predominantly negative work (red-coloured pressure-strain loop area), which leads to a large lateral-to-septal work difference. (B) LGE-CMR revealed extensive septal scar with limited potential for recovery of septal function with cardiac resynchronization therapy. (C) After 6 months with cardiac resynchronization therapy, there is only moderate recovery of septal function and, despite reduced workload on the left ventricular lateral wall, still significant lateral-to-septal work difference. AVC, aortic valve closure; LGE-CMR, late gadolinium enhancement cardiac magnetic resonance; LVP, left ventricular pressure.
Figure 4Work asymmetry and septal viability as predictors of cardiac resynchronization therapy response. (A) Receiver operating characteristic curve displaying lateral-to-septal work difference as predictor of cardiac resynchronization therapy response in the entire study population (n = 195). (B) Receiver operating characteristic curve displaying the combined assessment of lateral-to-septal work difference and septal viability as predictor of cardiac resynchronization therapy response (n = 123). AUC, area under curve; CI, confidence interval.
Figure 5Association of work asymmetry and septal viability with long-term survival. (A) Kaplan–Meier curve stratified according to the proposed cut-off value for lateral-to-septal work difference. (B) Kaplan–Meier curve stratified according to the proposed cut-off value for lateral-to-septal work difference combined with septal viability.
Baseline characteristics
| All patients ( | Responders ( | Non-responders ( |
| |
|---|---|---|---|---|
| Age (years) | 67 ± 11 | 68 ± 11 | 65 ± 11 | 0.041 |
| Gender (%) | ||||
| Male | 71 | 65 | 83 | 0.009 |
| Weight (kg) | 79 ± 16 | 75 ± 14 | 85 ± 17 | <0.001 |
| Heart failure aetiology (%) | ||||
| Non-ischaemic | 65 | 76 | 43 | <0.001 |
| Ischaemic | 35 | 24 | 57 | <0.001 |
| Medication (%) | ||||
| ACE-inhibitor/ARB | 95 | 97 | 89 | 0.023 |
| Beta-blocker | 90 | 89 | 92 | 0.450 |
| Aldosterone antagonists | 41 | 39 | 46 | 0.304 |
| Diuretics | 71 | 69 | 77 | 0.263 |
| Rhythm (%) | ||||
| Sinus | 82 | 86 | 72 | 0.020 |
| Atrial fibrillation | 6 | 4 | 8 | 0.345 |
| Paced | 13 | 11 | 20 | 0.041 |
| QRS configuration (%) | ||||
| LBBB | 86 | 90 | 78 | 0.033 |
| Non-LBBB | 14 | 10 | 22 | 0.033 |
| QRS duration (ms) | 167 ± 21 | 168 ± 19 | 166 ± 24 | 0.497 |
| Upgrades (%) | 22 | 16 | 35 | 0.002 |
| Systolic blood pressure (mmHg) | 124 ± 21 | 126 ± 21 | 119 ± 20 | 0.020 |
| Diastolic blood pressure (mmHg) | 69 ± 11 | 70 ± 12 | 68 ± 10 | 0.318 |
| NYHA functional class | 2.4 ± 0.6 | 2.3 ± 0.6 | 2.5 ± 0.6 | 0.030 |
| Mitral regurgitation (0–3) | 1.2 ± 0.8 | 1.1 ± 0.8 | 1.4 ± 0.9 | 0.053 |
Continuous variables are given as mean ± standard deviation. P-value for comparison of responders vs. non-responders.
ACE-inhibitor, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; LBBB, left bundle branch block; NYHA, New York Heart Association.
Multivariate linear regression analysis with left ventricular end-systolic volume reduction as dependent variable
| Regression variable |
| VIF | 95% CI |
|
|---|---|---|---|---|
| Constant term | 22.3 | |||
| QRS morphology | 4.67 | 1.09 | −4.65 to 13.99 | 0.324 |
| QRS duration | −0.165 | 1.00 | −0.317 to −0.014 | 0.033 |
| Heart failure aetiology | −15.9 | 1.07 | −22.6 to −9.3 | <0.0001 |
| LW-S work difference | −0.011 | 1.15 | −0.015 to −0.007 | <0.0001 |
N = 190. R2 = 0.29.
CI, confidence interval; LW-S, lateral wall-to-septal; VIF, variance inflation factors.
Multivariate linear regression analysis with left ventricular end-systolic volume reduction as dependent variable
| Regression variable |
| VIF | 95% CI |
|
|---|---|---|---|---|
| Constant term | −40.0 | |||
| Anterior wall scar | 0.31 | 2.87 | −0.05 to 0.66 | 0.088 |
| Septal scar | 0.42 | 3.17 | 0.04 to 0.80 | 0.029 |
| Inferior wall scar | 0.11 | 3.09 | −0.22 to 0.45 | 0.503 |
| Lateral wall scar | 0.12 | 2.94 | −0.21 to 0.45 | 0.479 |
N = 122. R2 = 0.33. Regional scar was given as a continuous variable (%).
CI, confidence interval; VIF, variance inflation factors.
Multivariate linear regression analysis with left ventricular end-systolic volume reduction as dependent variable
| Regression variable |
| VIF | 95% CI |
|
|---|---|---|---|---|
| Constant term | −1.15 | |||
| QRS morphology | 8.70 | 1.13 | −4.36 to 21.77 | 0.190 |
| QRS duration | −0.15 | 1.07 | −0.36 to 0.06 | 0.167 |
| LW-S work difference | −0.009 | 1.13 | −0.014 to −0.005 | <0.0002 |
| Septal scar | 0.56 | 1.11 | 0.35 to 0.78 | <0.0001 |
N = 121. R2 = 0.40. Septal scar was given as a continuous variable (%).
CI, confidence interval; LW-S, lateral wall-to-septal; VIF, variance inflation factors.